Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer

被引：0

作者：

M. Majem

J. Hernández-Hernández

F. Hernando-Trancho

N. Rodríguez de Dios

A. Sotoca

J. C. Trujillo-Reyes

I. Vollmer

R. Delgado-Bolton

M. Provencio

机构：

[1] Hospital de la Santa Creu i Sant Pau,Department of Medical Oncology

[2] Complejo Asistencial de Ávila,undefined

[3] Hospital Clínico San Carlos,undefined

[4] Hospital del Mar,undefined

[5] Hospital Ruber Internacional,undefined

[6] Hospital Clínic,undefined

[7] Hospital San Pedro,undefined

[8] CIBIR,undefined

[9] Hospital Universitario Puerta de Hierro,undefined

来源：

Clinical and Translational Oncology | 2020年 / 22卷

关键词：

Lung cancer; Multimodal management; Staging; Multidisciplinary team; Induction therapy; Chemotherapy; Radiotherapy; Surgery;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Stage III non-small cell lung cancer (NSCLC) is a very heterogeneous disease that encompasses patients with resected, potentially resectable and unresectable tumours. To improve the prognostic capacity of the TNM classification, it has been agreed to divide stage III into sub-stages IIIA, IIIB and IIIC that have very different 5-year survival rates (36, 26 and 13%, respectively). Currently, it is considered that both staging and optimal treatment of stage III NSCLC requires the joint work of a multidisciplinary team of expert physicians within the tumour committee. To improve the care of patients with stage III NSCLC, different scientific societies involved in the diagnosis and treatment of this disease have agreed to issue a series of recommendations that can contribute to homogenise the management of this disease, and ultimately to improve patient care.

引用

页码：21 / 36

页数：15

共 708 条

[1] Rami-Porta R(2015)The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer J Thorac Oncol 10 990-1003
[2] Bolejack V(2018)Lung cancer staging: a concise update Eur Respir J. 51 1800190-51
[3] Crowley J(2016)The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer J Thorac Oncol. 11 39-W44
[4] Ball D(2011)ACR Appropriateness Criteria(R) acute respiratory illness in immunocompetent patients J Thorac Imaging 26 W42-23
[5] Kim J(2015)Recommendations for radiological diagnosis and assessment of treatment response in lung cancer: a national consensus statement by the Spanish Society of Medical Radiology and the Spanish Society of Medical Oncology Clin Transl Oncol 17 11-62
[6] Lyons G(2011)Optimal anatomic coverage for CT in staging lung cancer: lessons from PET-CT correlation Lung Cancer. 73 59-208
[7] Rami-Porta R(2010)Cine MRI enables better therapeutic planning than CT in cases of possible lung cancer chest wall invasion Lung Cancer. 69 203-886
[8] Call S(2008)Ultrasound vs. CT in detecting chest wall invasion by tumor: a prospective study Chest. 133 881-572
[9] Dooms C(2008)Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response Radiographics. 28 561-161
[10] Obiols C(2014)Mediastinal staging for lung cancer Can Respir J. 21 159-892

← 1 2 3 4 5 6 7 8 9 10 →